BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 19350175)

  • 1. [Gran versus host disease with oral involvement: report of one case].
    Rojas A G; González G N; Venables G C; Araos H D
    Rev Med Chil; 2008 Dec; 136(12):1570-3. PubMed ID: 19350175
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Topical cyclosporin A for treatment of oral chronic graft-versus-host disease.
    Epstein JB; Reece DE
    Bone Marrow Transplant; 1994 Jan; 13(1):81-6. PubMed ID: 8019458
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Topical azathioprine in the combined treatment of chronic oral graft-versus-host disease.
    Epstein JB; Nantel S; Sheoltch SM
    Bone Marrow Transplant; 2000 Mar; 25(6):683-7. PubMed ID: 10734307
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Severe oral chronic graft-versus-host disease following allogeneic bone marrow transplantation: highly effective treatment with topical tacrolimus.
    Eckardt A; Starke O; Stadler M; Reuter C; Hertenstein B
    Oral Oncol; 2004 Sep; 40(8):811-4. PubMed ID: 15288836
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral graft vs. host disease in children--treatment with topical tacrolimus ointment.
    Albert MH; Becker B; Schuster FR; Klein B; Binder V; Adam K; Nienhoff C; Führer M; Borkhardt A
    Pediatr Transplant; 2007 May; 11(3):306-11. PubMed ID: 17430488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic graft versus host disease of oral mucosa: review of available therapies.
    Imanguli MM; Pavletic SZ; Guadagnini JP; Brahim JS; Atkinson JC
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2006 Feb; 101(2):175-83. PubMed ID: 16448918
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Squamous cell carcinoma of the oral cavity associated with graft versus host disease: report of a case and review of the literature.
    Demarosi F; Soligo D; Lodi G; Moneghini L; Sardella A; Carrassi A
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2005 Jul; 100(1):63-9. PubMed ID: 15953918
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral graft-versus-host disease.
    Schubert MM; Correa ME
    Dent Clin North Am; 2008 Jan; 52(1):79-109, viii-ix. PubMed ID: 18154866
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Successful treatment of oral lichen planus-like chronic graft-versus-host disease with topical tacrolimus: a case report.
    Sánchez AR; Sheridan PJ; Rogers RS
    J Periodontol; 2004 Apr; 75(4):613-9. PubMed ID: 15152828
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Graft-versus-host disease, an eight case report and literature review.
    de la Rosa García E; Bologna Molina R; Vega González Tde J
    Med Oral Patol Oral Cir Bucal; 2006 Nov; 11(6):E486-92. PubMed ID: 17072252
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FK506 (tacrolimus) in the treatment of steroid-resistant acute graft-versus-host disease in children undergoing bone marrow transplantation.
    Koehler MT; Howrie D; Mirro J; Neudorf S; Blatt J; Corey S; Wollman M; Kelly-Ekeroth V; Reyes J
    Bone Marrow Transplant; 1995 Jun; 15(6):895-9. PubMed ID: 7581088
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term efficacy of topical tacrolimus on oral lesions of chronic graft-versus-host disease.
    Fricain JC; Sibaud V; Swetyenga N; Tabrizi R; Campana F; Taïeb A
    Br J Dermatol; 2007 Mar; 156(3):588-90. PubMed ID: 17300261
    [No Abstract]   [Full Text] [Related]  

  • 13. Salivary gland involvement in graft-versus-host disease: the underlying mechanism and implicated treatment.
    Nagler RM; Nagler A
    Isr Med Assoc J; 2004 Mar; 6(3):167-72. PubMed ID: 15055275
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral involvement in chronic graft versus host disease: a prospective study of 19 Brazilian patients.
    Pereira CM; de Almeida OP; Correa ME; Souza CA; Barjas-Castro ML
    Gen Dent; 2007; 55(1):48-51. PubMed ID: 17333967
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Immunosuppressive drugs in the prevention and treatment of GVHD after allogenic bone marrow transplantation].
    Basić-Jukić N; Labar B
    Acta Med Croatica; 2003; 57(2):131-9. PubMed ID: 12879693
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pemphigoid-like ocular lesions in patients with graft-versus-host disease following allogeneic bone marrow transplantation.
    Karwacka E; Ołdakowska-Jedynak U; Brydak-Godowska J; Paczek L; Kecik D
    Transplant Proc; 2006; 38(1):292-4. PubMed ID: 16504728
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bone marrow transplantation for severe aplastic anemia.
    Storb R; Champlin RE
    Bone Marrow Transplant; 1991 Aug; 8(2):69-72. PubMed ID: 1933061
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The outcome of unrelated donor bone marrow transplantation in patients with hematologic malignancies using tacrolimus (FK506) and low dose methotrexate for graft-versus-host disease prophylaxis.
    Devine SM; Geller RB; Lin LB; Dix SP; Holland HK; Maurer D; O'Toole K; Keller J; Connaghan DG; Heffner LT; Hillyer CD; Rodey GE; Winton EF; Maher RM; Fitzsimmons WE; Wingard JR
    Biol Blood Marrow Transplant; 1997 Apr; 3(1):25-33. PubMed ID: 9209738
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Budesonide: a novel treatment for oral chronic graft versus host disease.
    Elad S; Or R; Garfunkel AA; Shapira MY
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2003 Mar; 95(3):308-11. PubMed ID: 12627101
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Bone marrow transplantation in aplastic anemia. Experience at a Mexican institution. Bone marrow transplantation group of the Salvador Zubirán National Institute of Nutrition].
    León-Rodríguez E; Sosa Sánchez R; Gómez E; Ochoa Sosa C
    Rev Invest Clin; 1993; 45(6):559-64. PubMed ID: 8159876
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.